Suppr超能文献

2 型糖尿病患者的难治性和耐药性高血压:对肾去神经支配的不同反应。

Refractory and Resistant Hypertension in Patients with Type 2 Diabetes Mellitus: Different Response to Renal Denervation.

机构信息

Research Institute of Cardiology, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk.

出版信息

Kardiologiia. 2021 Mar 9;61(2):54-61. doi: 10.18087/cardio.2021.2.n1102.

Abstract

Aim      To compare the antihypertensive effectivity of renal denervation in patients with diabetes mellitus (DM) and associated refractory arterial hypertension (rfAH) (treated with 5 or more classes of antihypertensive drugs, including a thiazide diuretic and a mineralocorticoid receptor antagonist) and uncontrolled resistant AH (ucAH) (treated with 3-4 drugs).Material and methods  This interventional study with renal denervation included 18 DM patients with rfAH and 40 DM patients with ucAH; 16 and 36 of them, respectively, completed the study in 6 months. At baseline, patients were sex- and age-matched. Study methods included measurement of office blood pressure (BP; systolic/diastolic BP, SBP/DBP); outpatient BP monitoring; evaluation of kidney function (estimated glomerular filtration rate by the CKD-EPI formula); diurnal diuresis volume; diurnal urinary excretion of albumin, potassium and sodium; diurnal excretion of metanephrines and normetanephrines; and plasma levels of glucose and glycated hemoglobin, aldosterone, and active renin. Patients were instructed about maintaining compliance with their antihypertensive and hypoglycemic therapy throughout the study.Results At baseline, patients of both groups were comparable by BP and major clinical indexes, except for higher values of nocturnal SBP variability (p<0.05) in patients with rfAH. At 6 months following renal denervation, both groups displayed significant decreases in office and average daily SBP and also in the "load" with increased mean diurnal SBP. However, the decrease in average daily SBP was almost 4 times greater in the rfAH group than in the ucAH group ( -19.9 and -5.1 mm Hg, respectively, р=0.02). Moreover, 81 % of patients in the rfAH group responded to the intervention (average daily SBP decrease ≥10 mm Hg) while the number of responders in the ucAH group was considerably smaller (42 %; p=0.02). In patients with rfAH, renal denervation was associated with a significant decrease in pulse BP and nocturnal SBP variability and with the increase in diurnal diuresis. No other alterations were noted in laboratory test results in either group.Conclusion      DM patients with rfAH may be the best candidates for the procedure of renal denervation.

摘要

目的

比较糖尿病(DM)合并难治性动脉高血压(rfAH,接受 5 种或以上降压药物治疗,包括噻嗪类利尿剂和盐皮质激素受体拮抗剂)和未控制的难治性高血压(ucAH,接受 3-4 种药物治疗)患者肾去神经术的降压效果。

材料和方法

这项肾去神经术的干预性研究纳入了 18 例 rfAH 的 DM 患者和 40 例 ucAH 的 DM 患者;其中分别有 16 例和 36 例患者在 6 个月时完成了研究。在基线时,患者在性别和年龄上相匹配。研究方法包括测量诊室血压(收缩压/舒张压,SBP/DBP);门诊血压监测;肾功能评估(CKD-EPI 公式估算肾小球滤过率);日间尿量;日间尿白蛋白、钾和钠排泄量;日间儿茶酚胺排泄量;血浆葡萄糖和糖化血红蛋白、醛固酮和活性肾素水平。患者在整个研究过程中被指导保持降压和降糖治疗的依从性。

结果

在基线时,两组患者的血压和主要临床指标相似,除了 rfAH 患者的夜间 SBP 变异性较高(p<0.05)。肾去神经术后 6 个月,两组患者的诊室和平均日常 SBP 以及日间平均 SBP 升高的“负荷”均显著下降。然而,rfAH 组的平均日常 SBP 下降幅度几乎是 ucAH 组的 4 倍(分别为-19.9 和-5.1mmHg,p=0.02)。此外,rfAH 组 81%的患者对干预有反应(平均日常 SBP 下降≥10mmHg),而 ucAH 组的反应者人数要少得多(42%;p=0.02)。在 rfAH 患者中,肾去神经术与脉搏 SBP 和夜间 SBP 变异性的显著降低以及日间尿量的增加相关,两组的实验室检查结果均无其他改变。

结论

rfAH 的 DM 患者可能是肾去神经术的最佳候选者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验